1	En	en	SPS00	C1720294#C0332285	calificador#atributo	312-314	317_QUEST_clinical_caseMIR	SENT1	-	-
2	la	el	DA0FS0	-	-	315-317	317_QUEST_clinical_caseMIR	SENT1	-	-
3	TC	símbolo_químico_del_tecnecio	NC00YL0	-	-	318-320	317_QUEST_clinical_caseMIR	SENT1	-	-
4	abdominal	abdominal	AQ0CS0	C0000726	calificador	321-330	317_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
5	se	se	P00CN000	-	-	331-333	317_QUEST_clinical_caseMIR	SENT1	-	-
6	observa	observar	VMIP3S0	-	-	334-341	317_QUEST_clinical_caseMIR	SENT1	-	-
7	una	una		C0205447_1	calificador_1	342-345	317_QUEST_clinical_caseMIR	SENT1	-	-
8	masa	masa	NCFS000	C0342500_1	hallazgo_1	346-350	317_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
9	suprarrenal	suprarrenal	NC00SC0	C0342500_2	hallazgo_2	351-362	317_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
10	derecha	derecho	AQ0FS0	C0445291#C0445292#C0205090#C0450415	calificador	363-370	317_QUEST_clinical_caseMIR	SENT1	I-Estructura_Corporal	-
11	,	,	Fc	-	-	370-371	317_QUEST_clinical_caseMIR	SENT1	-	-
12	indique	indicar	VMM03S0	-	-	372-379	317_QUEST_clinical_caseMIR	SENT1	-	-
13	qué	qué	DT0CN0	-	-	380-383	317_QUEST_clinical_caseMIR	SENT1	-	-
14	fármaco	fármaco	NCMS000	C0013227	sustancia	384-391	317_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
15	emplearía	emplear	VMIC3S0	-	-	392-401	317_QUEST_clinical_caseMIR	SENT1	-	-
16	en	en	SPS00	C1279901_1	calificador_1	402-404	317_QUEST_clinical_caseMIR	SENT1	-	-
17	primer	1	AO0MS0	C1279901_2	calificador_2	405-411	317_QUEST_clinical_caseMIR	SENT1	-	-
18	lugar	lugar	NCMS000	C1279901_3	calificador_3	412-417	317_QUEST_clinical_caseMIR	SENT1	-	-
19	para	para	SPS00	C0521125	calificador	418-422	317_QUEST_clinical_caseMIR	SENT1	-	-
20	evitar	evitar	VMN0000	-	-	423-429	317_QUEST_clinical_caseMIR	SENT1	-	-
21	la	el	DA0FS0	-	-	430-432	317_QUEST_clinical_caseMIR	SENT1	-	-
22	crisis	crisis	NCFN000	C0151620#C0020546_1	trastorno_1	433-439	317_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
23	hipertensiva	hipertensivo	AQ0FS0	C0151620#C0020546_2	trastorno_2	440-452	317_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
24	asociada	asociar	VMP00SF	-	-	453-461	317_QUEST_clinical_caseMIR	SENT1	-	-
25	a	a	SPS00	-	-	462-463	317_QUEST_clinical_caseMIR	SENT1	-	-
26	la	el	DA0FS0	-	-	464-466	317_QUEST_clinical_caseMIR	SENT1	-	-
27	inducción	inducción	NCFS000	-	-	467-476	317_QUEST_clinical_caseMIR	SENT1	-	-
28	anestésica	anestésico	AQ0FS0	C0002932#C0473161	sustancia#ocupación	477-487	317_QUEST_clinical_caseMIR	SENT1	-	-
29	:	:	Fd	-	-	487-488	317_QUEST_clinical_caseMIR	SENT1	-	-
30	Hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	0-6	317_QUEST_clinical_caseMIR	SENT1	-	-
31	de	de	SPS00	C0332285	atributo	7-9	317_QUEST_clinical_caseMIR	SENT1	-	-
32	65	65		-	-	10-12	317_QUEST_clinical_caseMIR	SENT1	-	-
33	años	año	NCMP000	C0439234	calificador	13-17	317_QUEST_clinical_caseMIR	SENT1	-	-
34	sin	sin	SPS00	C0332288	atributo	18-21	317_QUEST_clinical_caseMIR	SENT1	-	-
35	antecedentes	antecedente	NCMP000	C0455458_1	categoría_dependiente_del_contexto_1	22-34	317_QUEST_clinical_caseMIR	SENT1	-	-
36	médicos	médico	NCCP000	C0455458_2	categoría_dependiente_del_contexto_2	35-42	317_QUEST_clinical_caseMIR	SENT1	-	-
37	de	de	SPS00	C0455458_3	categoría_dependiente_del_contexto_3	43-45	317_QUEST_clinical_caseMIR	SENT1	-	-
38	interés	interés	NCMS000	-	-	46-53	317_QUEST_clinical_caseMIR	SENT1	-	-
39	que	que	CS	-	-	54-57	317_QUEST_clinical_caseMIR	SENT1	-	-
40	consulta	consultar	VMM02S0	C1704447_1	calificador_1	58-66	317_QUEST_clinical_caseMIR	SENT1	-	-
41	por	por	SPS00	C1704447_2	calificador_2	67-70	317_QUEST_clinical_caseMIR	SENT1	-	-
42	chorro	chorro	NCMS000	C0232851_1	entidad_observable_1	71-77	317_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
43	miccional	miccional		C0232851_2	entidad_observable_2	78-87	317_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
44	fino	fino	AQ0MS0	C0205232	calificador	88-92	317_QUEST_clinical_caseMIR	SENT1	-	-
45	,	,	Fc	-	-	92-93	317_QUEST_clinical_caseMIR	SENT1	-	-
46	sensación	sensación	NCFS000	C0036658#C1455667	calificador	94-103	317_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
47	de	de	SPS00	C0332285	atributo	104-106	317_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
48	vaciado	vaciado	NCMS000	-	-	107-114	317_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
49	incompleto	incompleto	AQ0MS0	C0728938#C0205257#C0728939	calificador	115-125	317_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
50	,	,	Fc	-	-	125-126	317_QUEST_clinical_caseMIR	SENT1	-	-
51	frecuencia	frecuencia	NCFS000	C2584336_1	entidad_observable_1	127-137	317_QUEST_clinical_caseMIR	SENT1	-	-
52	miccional	miccional		C2584336_2	entidad_observable_2	138-147	317_QUEST_clinical_caseMIR	SENT1	-	-
53	diurna	diurno	AQ0FS0	C0332169	calificador	148-154	317_QUEST_clinical_caseMIR	SENT1	-	-
54	cada	cada	NC00SC0	C1457900	calificador	155-159	317_QUEST_clinical_caseMIR	SENT1	-	-
55	3	3	Z	-	-	160-161	317_QUEST_clinical_caseMIR	SENT1	-	-
56	horas	h	NCFP000	C0439227	calificador	162-167	317_QUEST_clinical_caseMIR	SENT1	-	-
57	y	y	CC	C1706368	calificador	168-169	317_QUEST_clinical_caseMIR	SENT1	-	-
58	nicturia	nicturia	NC00SC0	C0028734	hallazgo	170-178	317_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
59	1-2	1-2		-	-	179-182	317_QUEST_clinical_caseMIR	SENT1	-	-
60	veces	vez	NCFP000	-	-	183-188	317_QUEST_clinical_caseMIR	SENT1	-	-
61	.	.	Fp	-	-	188-189	317_QUEST_clinical_caseMIR	SENT1	-	-

1	Al	al	SP+DA	-	-	190-192	317_QUEST_clinical_caseMIR	SENT2	-	-
2	tacto	tacto	NCMS000	C1384593_1	procedimiento_1	193-198	317_QUEST_clinical_caseMIR	SENT2	-	-
3	rectal	rectal	NC00SC0	C1384593_2	procedimiento_2	199-205	317_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
4	se	se	P00CN000	-	-	206-208	317_QUEST_clinical_caseMIR	SENT2	-	-
5	aprecia	apreciar	VMIP3S0	-	-	209-216	317_QUEST_clinical_caseMIR	SENT2	-	-
6	próstata	próstata	NCFS000	C1278980#C0033572	estructura_corporal	217-225	317_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
7	mediana-grande	mediana-grande	AQ0CS00	-	-	226-240	317_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
8	sin	sin	SPS00	C0332288	atributo	241-244	317_QUEST_clinical_caseMIR	SENT2	-	-
9	nodulos	nodulos	NCMP000	-	-	245-252	317_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	Negacion
10	.	.	Fp	-	-	252-253	317_QUEST_clinical_caseMIR	SENT2	-	-

1	Antígeno	antígeno	NCMS000	C0138741_1	sustancia_1	254-262	317_QUEST_clinical_caseMIR	SENT3	-	-
2	prostático	prostático	NC00SC0	C0138741_2	sustancia_2	263-273	317_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
3	específico	específico	NCMS000	C0138741_3	sustancia_3	274-284	317_QUEST_clinical_caseMIR	SENT3	-	-
4	(	(	Fpa	-	-	285-286	317_QUEST_clinical_caseMIR	SENT3	-	-
5	PSA	prostate-specific_antigen_(antígeno_prostático_específico)	NC00YL0	-	-	286-289	317_QUEST_clinical_caseMIR	SENT3	-	-
6	)	)	Fpt	-	-	289-290	317_QUEST_clinical_caseMIR	SENT3	-	-
7	0,5	0,5		-	-	291-294	317_QUEST_clinical_caseMIR	SENT3	-	-
8	ng	nasogástrico	NC00YL0	-	-	295-297	317_QUEST_clinical_caseMIR	SENT3	-	-
9	/	/	Fh	-	-	297-298	317_QUEST_clinical_caseMIR	SENT3	-	-
10	mL	mililitro	NCMN000	C0439242	calificador	298-300	317_QUEST_clinical_caseMIR	SENT3	-	-
11	.	.	Fp	-	-	300-301	317_QUEST_clinical_caseMIR	SENT3	-	-

1	Aporta	aportar	VMIP3S0	-	-	302-308	317_QUEST_clinical_caseMIR	SENT4	-	-
2	ecografía	ecografía	NCFS000	C0041618	calificador#procedimiento	309-318	317_QUEST_clinical_caseMIR	SENT4	-	-
3	reno-vésico_x0002_prostática	reno-vésico_x0002_prostática		-	-	319-347	317_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
4	que	que	PR0CN000	-	-	348-351	317_QUEST_clinical_caseMIR	SENT4	-	-
5	nos	nos	PP1CP000	-	-	352-355	317_QUEST_clinical_caseMIR	SENT4	-	-
6	indica	indicar	VMIP3S0	-	-	356-362	317_QUEST_clinical_caseMIR	SENT4	-	-
7	un	un		C0205447_1	calificador_1	363-365	317_QUEST_clinical_caseMIR	SENT4	-	-
8	volumen	volumen	NCMS000	C0449468#C0178733	calificador#hallazgo	366-373	317_QUEST_clinical_caseMIR	SENT4	-	-
9	prostático	prostático	AQ0MS0	C0033572	calificador	374-384	317_QUEST_clinical_caseMIR	SENT4	-	-
10	de	de	SPS00	C0332285	atributo	385-387	317_QUEST_clinical_caseMIR	SENT4	-	-
11	35	35	Z	-	-	388-390	317_QUEST_clinical_caseMIR	SENT4	-	-
12	g	g	NCMN000	-	-	391-392	317_QUEST_clinical_caseMIR	SENT4	-	-
13	,	,	Fc	-	-	392-393	317_QUEST_clinical_caseMIR	SENT4	-	-
14	con	con	SPS00	C0332287	atributo	394-397	317_QUEST_clinical_caseMIR	SENT4	-	-
15	ausencia	ausencia	NCFS000	C0332197_1	calificador_1	398-406	317_QUEST_clinical_caseMIR	SENT4	-	-
16	de	de	SPS00	C0332197_2	calificador_2	407-409	317_QUEST_clinical_caseMIR	SENT4	-	-
17	residuo	residuo	NCMS000	-	-	410-417	317_QUEST_clinical_caseMIR	SENT4	-	-
18	postmiccional	postmiccional	AQ0CS00	-	-	418-431	317_QUEST_clinical_caseMIR	SENT4	-	-
19	y	y	CC	C1706368	calificador	432-433	317_QUEST_clinical_caseMIR	SENT4	-	-
20	sin	sin	SPS00	C0332288	atributo	434-437	317_QUEST_clinical_caseMIR	SENT4	-	-
21	otras	otro	DI0FP0	C0205394#C0449210	calificador#estructura_corporal	438-443	317_QUEST_clinical_caseMIR	SENT4	-	-
22	alteraciones	alteración	NCFP000	-	-	444-456	317_QUEST_clinical_caseMIR	SENT4	-	-
23	valorables	valorable	AQ0CP0	-	-	457-467	317_QUEST_clinical_caseMIR	SENT4	-	-
24	.	.	Fp	-	-	467-468	317_QUEST_clinical_caseMIR	SENT4	-	-

1	¿	¿	Fia	-	-	469-470	317_QUEST_clinical_caseMIR	SENT5	-	-
2	Cuál	cuál	PT0CS000	-	-	470-474	317_QUEST_clinical_caseMIR	SENT5	-	-
3	será	ser	VSIF3S0	-	-	475-479	317_QUEST_clinical_caseMIR	SENT5	-	-
4	nuestra	nuestro	DP1FSP	-	-	480-487	317_QUEST_clinical_caseMIR	SENT5	-	-
5	actitud	actitud	NCFS000	C0004271	entidad_observable	488-495	317_QUEST_clinical_caseMIR	SENT5	-	-
6	ante	ante	SPS00	-	-	496-500	317_QUEST_clinical_caseMIR	SENT5	-	-
7	este	este	DD0MS0	-	-	501-505	317_QUEST_clinical_caseMIR	SENT5	-	-
8	paciente	paciente	NCCS000	C0030705	persona	506-514	317_QUEST_clinical_caseMIR	SENT5	-	-
9	?	?	Fit	-	-	514-515	317_QUEST_clinical_caseMIR	SENT5	-	-

